Blocknomi
Key Takeaways Shares of SYRE tumbled 14% during after-hours trading Tuesday following the company’s decision to discontinue SPY072 development as a standalone rheumatoid arthritis therapy SPY072 demonstrated superiority over placebo…
Related articles
-
Tether’s $120 million Uruguay bitcoin mining project collapsed over a power contract dispute: Reuters
The Block Published 23.08.2026 17:02
-
Tokenization Threatens Deposit Stability, Dallas Fed Researchers Warn
Bitcoin.com Published 28.08.2026 04:30
-
Wyoming Stable Token Commission Migrates Frontier Token to Chainlink CCIP
BlockchainReporter Published 20.08.2026 21:00
-
Ripple moves to shrink XRP Ledger attack surface as AI audit tests lending push
CryptoSlate Published 28.08.2026 17:45
-
Ethereum Rotation Takes Shape, Tom Lee Claims
U.Today Published 24.08.2026 09:25
-
Equinix (EQIX) Stock Climbs 2% Following Major Nvidia Partnership Announcement
Blocknomi Published 02.09.2026 12:31
-
Bitcoin Price Slams Into $79K Wall as Rally Momentum Starts Fading
Bitcoin.com Published 26.08.2026 20:30
-
Trump Warns Towns Rejecting Data Centers Will End Up “Backwards and Poor”
BeInCrypto Published 01.09.2026 07:19